Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM
Nov 7, 2023 08:30AM
Sep 27, 2023 08:30AM
Aug 17, 2023 08:31AM
Aug 17, 2023 08:30AM
Aug 15, 2023 08:30AM Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
Aug 1, 2023 08:30AM
Aug 1, 2023 08:30AM
May 16, 2023 08:00AM
May 2, 2023 04:30PM
Apr 18, 2023 08:45AM
Mar 21, 2023 08:38AM
Mar 21, 2023 08:35AM Composition of Matter Patent for QN-302 Granted by United States Patent and Trademark Office
Mar 15, 2023 09:05AM
Feb 1, 2023 09:05AM
Feb 1, 2023 09:05AM
Jan 24, 2023 09:00AM
Jan 23, 2023 09:02AM
Jan 10, 2023 09:02AM
Jan 10, 2023 09:00AM Qualigen Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for QN-302, a G-Quadruplex (G4) Transcription Inhibitor for the Intended Indication of Pancreatic Canc
Jan 5, 2023 09:00AM
Dec 12, 2022 08:37AM
Dec 12, 2022 08:30AM
Dec 7, 2022 09:11AM
Dec 7, 2022 09:10AM
Nov 22, 2022 09:00AM
Nov 22, 2022 09:00AM Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
Nov 15, 2022 07:30AM
Oct 19, 2022 09:00AM
Oct 19, 2022 09:00AM
Oct 18, 2022 09:00AM
Oct 18, 2022 09:00AM
Oct 6, 2022 08:00AM
Oct 6, 2022 08:00AM Qualigen Therapeutics to Present Two Posters at the National Cancer Institute Fourth RAS Initiative Symposium
Sep 14, 2022 05:03PM
Sep 14, 2022 05:02PM
Sep 14, 2022 05:02PM
Aug 18, 2022 09:15AM
Aug 18, 2022 09:15AM
Aug 16, 2022 07:30AM
Aug 16, 2022 07:30AM Qualigen Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 1, 2022 08:30AM
Aug 1, 2022 08:30AM
Aug 1, 2022 08:30AM
Jul 6, 2022 09:08AM
Jul 6, 2022 09:00AM
Jul 6, 2022 09:00AM
Jun 14, 2022 09:00AM Qualigen Therapeutics to Present at BIO International Convention
Jun 14, 2022 09:00AM

322,942 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All